eiCHO

About Triplebar

Triplebar is a private, pre-revenue biotech platform company leveraging a proprietary combination of AI and microfluidics to engineer biological solutions at unprecedented speed and scale. The company's core technology enables the high-throughput screening of billions of genetic variants to generate application-specific datasets and develop products across therapeutics, food, and agriculture. With a seasoned leadership team and strategic partnerships, Triplebar is positioned to disrupt traditional bio-engineering, though it faces significant competition and technical execution risks in a capital-intensive sector.

Therapeutic Areas

Other Biologics Production Drugs